In addition, loss of IGFBP2 expression is negatively associated with higher expression of cytokines—TNF-α and IL6—and chemokine—CCR5 in AEC2 cells of patients with severe and moderate COVID compared to those with IPF alone. Here, IGFBP2 is linked to idiopathic pulmonary fibrosis.